Mandatory PPA Drug Warning Disclosure

Ask AI

BFAD BUREAU CIRCULAR NO. 03-A: Mandatory PPA Drug Warning Disclosure

Getting related questions...
What do you want to know about the law?
Your conversations and searches stay on your device. We do not store or track your activity on our servers. To know more about our privacy commitment see jur.ph/privacy Ask AI provides quick answers grounded in full case texts to avoid mistakes. Always verify with the original text.

Ask AI

Title Supreme Court: Mandatory PPA Drug Warning Disclosure

Law: Bfad Bureau Circular No. 03-a

Decision Date: Mar 17, 2003

Drug manufacturers and distributors must provide patient information leaflets detailing precautions and warnings for products containing phenylpropanolamine (PPA), ensuring consumers are informed of safe usage and potential health risks.

drug products

patient information

drug manufacturers

END